Karsten Häffner

Title: The Innovations of Karsten Häffner

Introduction

Karsten Häffner is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that inhibit complement activation. With a total of 2 patents to his name, Häffner's work is paving the way for advancements in therapeutic applications.

Latest Patents

Häffner's latest patents focus on innovative polypeptides designed to inhibit complement activation. The first patent describes a polypeptide that comprises a C3 convertase effector domain, a C5 convertase effector domain, and optionally a terminal complex inhibitory effector domain. This polypeptide is resistant to deregulation by physiological FHR-Proteins and features a dimerization motif, enhancing its therapeutic potential. The second patent mirrors the first, emphasizing the importance of these polypeptides in medical applications.

Career Highlights

Throughout his career, Karsten Häffner has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Eleva GmbH and Greenovation Biotech GmbH. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.

Collaborations

Häffner has collaborated with various professionals, including his coworker Stefan Michelfelder. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Karsten Häffner's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work on polypeptides for inhibiting complement activation showcases the potential for therapeutic advancements.